Q2 19 results in line EBITDA-wise, with a US$1bn impairment on Ilva and the US at the EBIT level The group is doing well on the deleveraging front The outlook for H2 is not very optimistic on the price/ demand sides We will revise our estimates down for the current year, with a downward impact on the valuation
01 Aug 2019
Q2 19: in line but the outlook is rather cautious
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Q2 19: in line but the outlook is rather cautious
MaireTecnimont SpA (0QEP:LON) | 0 0 -0.2% | Mkt Cap: 1,153m
- Published:
01 Aug 2019 -
Author:
Fabrice Farigoule -
Pages:
3
Q2 19 results in line EBITDA-wise, with a US$1bn impairment on Ilva and the US at the EBIT level The group is doing well on the deleveraging front The outlook for H2 is not very optimistic on the price/ demand sides We will revise our estimates down for the current year, with a downward impact on the valuation